Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Additionally, a significant announcement regarding the modernization of ClinicalTrials.gov data ingest has been deleted.
    Difference
    1.0%
    Check dated 2025-07-04T04:08:08.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.8%
    Check dated 2025-06-19T19:53:26.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:17:53.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:00:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.1%
    Check dated 2025-04-30T14:21:57.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed information about a Phase II trial studying the combination of azacitidine and pembrolizumab for myelodysplastic syndrome, while retaining some identifiers and collaborators related to the study.
    Difference
    55%
    Check dated 2025-04-16T10:44:26.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.